Gene · 406967
Papers3,717
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,717
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrating platelet-rich plasma therapy into nursing practice: a review of biological mechanisms and clinical applications. | Front Bioeng Biotechnol | 2026 | 41768133 | PubTator, text mining | PubMed |
| RNA Regulatory Networks: Key Hubs in the Panorama of Cancer and Emerging Therapeutic Targets. | MedComm (2020) | 2026 | 41756253 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Liver Fibrosis: Pathogenic Messengers, Diagnostic Biomarkers, and Therapeutic Nanovectors. | Pharmaceutics | 2026 | 41754972 | PubTator, text mining | PubMed |
| Cross-Cultural Nutritional Epigenomics: Diet and Microbiome Interactions Shaping Type 2 Diabetes in Arab and Western Populations. | Nutrients | 2026 | 41754199 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Biomarkers and Non-Surgical Therapeutics in Cardiovascular Diseases. | J Clin Med | 2026 | 41753224 | PubTator, text mining | PubMed |
| An Exploratory Biomarker Study of First-Trimester Circulating miRNAs Associated with Later Gestational Diabetes Mellitus. | Int J Mol Sci | 2026 | 41752058 | PubTator, text mining | PubMed |
| Therapeutic Potential of Extracellular Vesicles: From Biogenesis, Isolation and Molecular Characterization to Addressing Translational Gaps and Regulatory Barriers. | Int J Mol Sci | 2026 | 41751812 | PubTator, text mining | PubMed |
| Exosomal bioactive molecules: molecular regulation, functional heterogeneity, and translational implications in disease diagnostics and therapeutics. | Clin Exp Med | 2026 | 41748937 | PubTator, text mining | PubMed |
| Genetic association of miR-146a, miR-196a2, and miR-499 polymorphisms with hepatocellular carcinoma risk in an Eastern Chinese population. | Front Oncol | 2026 | 41727633 | PubTator, text mining | PubMed |
| MicroRNA‑microbiome cross‑kingdom networks drive inflammatory bowel disease through dynamic regulatory ecosystems (Review). | Int J Mol Med | 2026 | 41614418 | PubTator, text mining | PubMed |
| Research Progress of Exosome-Derived microRNA in Alcohol Use Disorders: A Critical Review. | Addict Biol | 2026 | 41603274 | PubTator, text mining | PubMed |
| Assessment circulating micro-RNA-192 in Egyptian patients with non-viral liver cirrhosis and hepatocellular carcinoma. | Discov Oncol | 2026 | 41575695 | PubTator, text mining | PubMed |
| Epigenetic alterations in rotator cuff tendinopathy and degenerative cuff tears: a systematic review. | JSES Rev Rep Tech | 2026 | 41536319 | PubTator, text mining | PubMed |
| A p53-responsive microRNA-100 released from cardiomyoblasts serves as an early biomarker for acute coronary syndrome. | Hum Cell | 2026 | 41483378 | PubTator, text mining | PubMed |
| miRNA in the Progression of Diabetic Kidney Disease: New Insight. | Int J Mol Sci | 2025 | 41516293 | PubTator, text mining | PubMed |
| MicroRNAs diagnostic value or IgAN: a meta-analysis. | BMC Nephrol | 2025 | 41449328 | PubTator, text mining | PubMed |
| miRNAs as potential biomarkers for early detection of prediabetes among obesity: a systematic review. | Biosci Rep | 2025 | 41400625 | PubTator, text mining | PubMed |
Impact of an 8-week home-based resistance training and leisure-time physical activity on serum glucagon-like peptide-1 and microRNA-192 levels in children with type 1 diabetes: A randomized clinical trial. | J Res Med Sci | 2025 | 41306622 | PubTator, text mining | PubMed |
| MicroRNA Signatures in Serous Ovarian Cancer: A Comparison of Prognostic Marker Targets in African Americans and Caucasians. | Diseases | 2025 | 41294900 | PubTator, text mining | PubMed |
| Potential diagnostic value of microRNAs in vascular complications of diabetes: A systematic review and meta-analysis. | J Endocrinol Invest | 2025 | 41222881 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406967/papers?page=2